The lab of Madelon Maurice, Ph.D. in the Netherlands is amongst the leading labs studying the role of Wnt signaling in cancer. A promising target for future cancer therapeutics? #1…
Nicole VerbeeckApril 3, 2019
Can artificial intelligence bring down cancer deaths?
The death rate from cancer in the US has dropped 27% over the past 25 years, according to annual statistics…
Read more
Progress and impact
How far have we progressed in creating a world free of cancer, infectious killers or diabetes? Who’s making moves in key domains of healthcare innovation? What will we be able to achieve in the next decade and how to get there?
Dr. Bertalan Meskó – Director of the Medical Futurist Institute believes that healthcare needs a trip to Mars: we’d have healthcare systems that are accessible, personalized, preventative and augmented. Meskó argues…
Gemma MilneFebruary 24, 2019
The end product of where anything is going is to a patient, so bench to bedside always. And if you don’t have the narrative of the patient from the very…
Gemma MilneFebruary 8, 2019
We are at level today that for certain biologies, tissues and organs there is enough biological knowledge to use that knowledge in engineering regenerative solutions.
Nicole VerbeeckFebruary 7, 2019
Polleux lab located at Columbia University in the Department of Neuroscience and the Zuckerman Mind Brain Behavior Institute in New York unraveled the first signaling pathway that triggers synaptic loss in Alzheimer's…
Nicole VerbeeckFebruary 13, 2019
The NHS is the world’s largest nationalised healthcare system. Imagine how medicine can be transformed if one of the richest sources of medical data on earth could be unlocked.
Gemma MilneMarch 25, 2019
Former GSK SVP Dr. Paul-Peter Tak believes entrepreneurship should be at the heart of pharma. Tak created the Immunology Network and is now Venture Partner at Flagship Pioneering.
Gemma MilneMarch 19, 2019
Dr. Bettina Experton, CEO of California-based mobile health technology company Humetrix talks about empowering people with technology tools they know about.
Nicole VerbeeckMarch 4, 2019
The affordability of healthcare is high on the agenda of Tineke Van hooland. She believes in a three-track approach.
Nicole VerbeeckFebruary 4, 2019
Adrian Thomas of Johnson & Johnson Global Public Health doesn’t want to bore us with the numbers, but he’s on a mission to develop new drugs, new regimens, and new…
Gemma MilneFebruary 3, 2019
Prof. Dr. Karim Vermaelen of Ghent University, Belgium is working to crack the immunological code of lung cancer. And define for each patient which is the ideal combination therapy to…
Nicole VerbeeckMarch 11, 2019
Soon, 5 years from now we will see disposable diagnostics become available. Jo De Boeck, Chief Technology Officer and Executive Vice President at imec talks about technology becoming a key…
Nicole VerbeeckFebruary 5, 2019
Generation Moonshot
Rahul Remanan is on a quest to bring cancer down to zero, with the help of artificial intelligence. As the co-founder of the New York Healthcare Artificial Intelligence Society (NYHAIS)…
